Enabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop
Kevin M Koo1, Eugene J H Wee, Yuling Wang
1Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, QLD 4072, Australia. m.trau@uq.edu.au.
Lab on a Chip
|August 30, 2017
Summary
Lab-in-a-drop (LID) systems offer a novel approach to personalized diagnostics, integrating nucleic acid biomarker detection within a single fluid droplet. This solution-based platform bypasses complex engineering, enabling rapid, point-of-care disease detection.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Point-of-Care Testing
Background:
- Personalized diagnostics rely on individual molecular profiles for accurate clinical decisions.
- Lab-on-a-chip (LOC) systems miniaturize sample-to-outcome nucleic acid (NA) biomarker detection.
- LOC technology faces challenges in widespread adoption due to complex engineering requirements.
Purpose of the Study:
- To review miniaturized solution-based nucleic acid (NA) biosensing strategies for integrated lab-in-a-drop (LID) personalized diagnostics.
- To highlight advancements in LID systems as an alternative to complex LOC fabrication.
- To discuss future directions for LID platforms in personalized medicine.
Main Methods:
- Evaluation of three fundamental bioassay steps for miniaturized NA biomarker detection: crude sample preparation, isothermal target amplification, and amplicon detection readout.
- Analysis of research advancements integrating these steps into a functional LID system.
- Review of existing literature on miniaturized LOC fabrication and NA biomarker sensing.
Main Results:
- Lab-in-a-drop (LID) systems present a viable alternative to traditional lab-on-a-chip (LOC) devices for personalized diagnostics.
- Solution-based biosensing strategies are crucial for integrating sample preparation, amplification, and detection within a single droplet.
- Recent research shows progress towards a fully integrated LID system for point-of-care nucleic acid biomarker detection.
Conclusions:
- Lab-in-a-drop (LID) systems offer a promising, fabrication-free approach for point-of-care personalized diagnostics.
- Further research into integrated solution-based biosensing is key to realizing the full potential of LID platforms.
- LID technology holds significant promise for advancing personalized medicine through accessible and rapid disease detection.
